5-132865726-G-A

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_005260.7(GDF9):​c.-1193C>T variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.494 in 151,974 control chromosomes in the GnomAD database, including 19,537 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.49 ( 19536 hom., cov: 31)
Exomes 𝑓: 0.50 ( 1 hom. )

Consequence

GDF9
NM_005260.7 5_prime_UTR

Scores

3

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.0420

Publications

10 publications found
Variant links:
Genes affected
GDF9 (HGNC:4224): (growth differentiation factor 9) This gene encodes a secreted ligand of the TGF-beta (transforming growth factor-beta) superfamily of proteins. Ligands of this family bind various TGF-beta receptors leading to recruitment and activation of SMAD family transcription factors that regulate gene expression. The encoded preproprotein is proteolytically processed to generate each subunit of the disulfide-linked homodimer. This protein regulates ovarian function. Reduced expression of this gene may be associated with polycystic ovary syndrome and mutations in this gene may be more common in mothers of dizygotic twins. [provided by RefSeq, Jul 2016]
GDF9 Gene-Disease associations (from GenCC):
  • premature ovarian failure 14
    Inheritance: AR, AD Classification: STRONG, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_005260.7, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.81).
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.599 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_005260.7. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GDF9
NM_005260.7
MANE Select
c.-1193C>T
5_prime_UTR
Exon 1 of 2NP_005251.1O60383
GDF9
NM_001288824.4
c.-32+873C>T
intron
N/ANP_001275753.1B4DXG3
GDF9
NM_001288825.4
c.-147-254C>T
intron
N/ANP_001275754.1B4DXG3

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GDF9
ENST00000687138.1
MANE Select
c.-1193C>T
5_prime_UTR
Exon 1 of 2ENSP00000510441.1O60383
GDF9
ENST00000464378.2
TSL:2
c.-1118C>T
5_prime_UTR
Exon 1 of 3ENSP00000509893.1O60383
GDF9
ENST00000621295.5
TSL:5
c.-334C>T
5_prime_UTR
Exon 1 of 3ENSP00000484339.1B4DXG3

Frequencies

GnomAD3 genomes
AF:
0.494
AC:
75064
AN:
151846
Hom.:
19535
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.335
Gnomad AMI
AF:
0.651
Gnomad AMR
AF:
0.517
Gnomad ASJ
AF:
0.598
Gnomad EAS
AF:
0.318
Gnomad SAS
AF:
0.618
Gnomad FIN
AF:
0.498
Gnomad MID
AF:
0.525
Gnomad NFE
AF:
0.583
Gnomad OTH
AF:
0.496
GnomAD4 exome
AF:
0.500
AC:
5
AN:
10
Hom.:
1
AF XY:
0.500
AC XY:
4
AN XY:
8
show subpopulations
African (AFR)
AC:
0
AN:
0
American (AMR)
AC:
0
AN:
0
Ashkenazi Jewish (ASJ)
AC:
0
AN:
0
East Asian (EAS)
AC:
0
AN:
0
South Asian (SAS)
AC:
0
AN:
0
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
2
Middle Eastern (MID)
AC:
0
AN:
0
European-Non Finnish (NFE)
AF:
0.750
AC:
3
AN:
4
Other (OTH)
AF:
0.500
AC:
2
AN:
4
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.525
Heterozygous variant carriers
0
1
2
2
3
4
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.494
AC:
75098
AN:
151964
Hom.:
19536
Cov.:
31
AF XY:
0.493
AC XY:
36604
AN XY:
74262
show subpopulations
African (AFR)
AF:
0.335
AC:
13866
AN:
41418
American (AMR)
AF:
0.517
AC:
7888
AN:
15270
Ashkenazi Jewish (ASJ)
AF:
0.598
AC:
2071
AN:
3464
East Asian (EAS)
AF:
0.319
AC:
1644
AN:
5160
South Asian (SAS)
AF:
0.617
AC:
2970
AN:
4812
European-Finnish (FIN)
AF:
0.498
AC:
5258
AN:
10558
Middle Eastern (MID)
AF:
0.537
AC:
158
AN:
294
European-Non Finnish (NFE)
AF:
0.583
AC:
39599
AN:
67968
Other (OTH)
AF:
0.498
AC:
1050
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1903
3807
5710
7614
9517
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
674
1348
2022
2696
3370
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.548
Hom.:
64483
Bravo
AF:
0.482
Asia WGS
AF:
0.469
AC:
1630
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.81
CADD
Benign
3.7
DANN
Benign
0.62
PhyloP100
0.042
PromoterAI
0.031
Neutral
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs39830;
hg19: chr5-132201418;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.